“…1,16,22 Many chemotherapy agents have known pulmonary toxicities, 24 so even stricter lung constraints are suggested for concurrent chemoradiotherapy. 25 Developing treatment techniques that lower the pneumonitis probability is more pressing in the context of the recent dose escalation attempts for NSCLC patients. In this publication, we do not attempt to correlate the lung dose distribution to pulmonary complications: we are looking for the plan- ning techniques that maximize the lung volume receiving almost no radiation.…”